Veterinary Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Live Attenuated Vaccines Inactivated Vaccines Others Segment by Application Livestock Swine Chicken Dog & Cat Others By Company Merck Zoetis Boehringer Ingelheim Ceva CAHIC HVRI Ringpu Biology Yebio DHN WINSUN Elanco Virbac Jinyu Bio-Technology ChengDu Tecbond CAVAC Kyoto Biken Laboratories FATRO Vaksindo Bio-Labs Avimex Animal Health MEVAC Biovac Atafen Dyntec BioTestLab RVSRI Medion By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Greece Ukraine Moldova Albania Serbia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Egypt South Africa Israel Kuwait Iran
1 Study Coverage 1.1 Veterinary Vaccine Product Introduction 1.2 Market by Type 1.2.1 Global Veterinary Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Live Attenuated Vaccines 1.2.3 Inactivated Vaccines 1.2.4 Others 1.3 Market by Application 1.3.1 Global Veterinary Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Livestock 1.3.3 Swine 1.3.4 Chicken 1.3.5 Dog & Cat 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Veterinary Vaccine Sales Estimates and Forecasts 2017-2028 2.2 Global Veterinary Vaccine Revenue Estimates and Forecasts 2017-2028 2.3 Global Veterinary Vaccine Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Veterinary Vaccine Sales by Region 2.4.1 Global Veterinary Vaccine Sales by Region (2017-2022) 2.4.2 Global Sales Veterinary Vaccine by Region (2023-2028) 2.5 Global Veterinary Vaccine Revenue by Region 2.5.1 Global Veterinary Vaccine Revenue by Region (2017-2022) 2.5.2 Global Veterinary Vaccine Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Veterinary Vaccine Sales by Manufacturers 3.1.1 Global Top Veterinary Vaccine Manufacturers by Sales (2017-2022) 3.1.2 Global Veterinary Vaccine Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Vaccine in 2021 3.2 Global Veterinary Vaccine Revenue by Manufacturers 3.2.1 Global Veterinary Vaccine Revenue by Manufacturers (2017-2022) 3.2.2 Global Veterinary Vaccine Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Veterinary Vaccine Revenue in 2021 3.3 Global Veterinary Vaccine Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Veterinary Vaccine Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Veterinary Vaccine Sales by Type 4.1.1 Global Veterinary Vaccine Historical Sales by Type (2017-2022) 4.1.2 Global Veterinary Vaccine Forecasted Sales by Type (2023-2028) 4.1.3 Global Veterinary Vaccine Sales Market Share by Type (2017-2028) 4.2 Global Veterinary Vaccine Revenue by Type 4.2.1 Global Veterinary Vaccine Historical Revenue by Type (2017-2022) 4.2.2 Global Veterinary Vaccine Forecasted Revenue by Type (2023-2028) 4.2.3 Global Veterinary Vaccine Revenue Market Share by Type (2017-2028) 4.3 Global Veterinary Vaccine Price by Type 4.3.1 Global Veterinary Vaccine Price by Type (2017-2022) 4.3.2 Global Veterinary Vaccine Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Veterinary Vaccine Sales by Application 5.1.1 Global Veterinary Vaccine Historical Sales by Application (2017-2022) 5.1.2 Global Veterinary Vaccine Forecasted Sales by Application (2023-2028) 5.1.3 Global Veterinary Vaccine Sales Market Share by Application (2017-2028) 5.2 Global Veterinary Vaccine Revenue by Application 5.2.1 Global Veterinary Vaccine Historical Revenue by Application (2017-2022) 5.2.2 Global Veterinary Vaccine Forecasted Revenue by Application (2023-2028) 5.2.3 Global Veterinary Vaccine Revenue Market Share by Application (2017-2028) 5.3 Global Veterinary Vaccine Price by Application 5.3.1 Global Veterinary Vaccine Price by Application (2017-2022) 5.3.2 Global Veterinary Vaccine Price Forecast by Application (2023-2028) 6 North America 6.1 North America Veterinary Vaccine Market Size by Type 6.1.1 North America Veterinary Vaccine Sales by Type (2017-2028) 6.1.2 North America Veterinary Vaccine Revenue by Type (2017-2028) 6.2 North America Veterinary Vaccine Market Size by Application 6.2.1 North America Veterinary Vaccine Sales by Application (2017-2028) 6.2.2 North America Veterinary Vaccine Revenue by Application (2017-2028) 6.3 North America Veterinary Vaccine Market Size by Country 6.3.1 North America Veterinary Vaccine Sales by Country (2017-2028) 6.3.2 North America Veterinary Vaccine Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Veterinary Vaccine Market Size by Type 7.1.1 Europe Veterinary Vaccine Sales by Type (2017-2028) 7.1.2 Europe Veterinary Vaccine Revenue by Type (2017-2028) 7.2 Europe Veterinary Vaccine Market Size by Application 7.2.1 Europe Veterinary Vaccine Sales by Application (2017-2028) 7.2.2 Europe Veterinary Vaccine Revenue by Application (2017-2028) 7.3 Europe Veterinary Vaccine Market Size by Country 7.3.1 Europe Veterinary Vaccine Sales by Country (2017-2028) 7.3.2 Europe Veterinary Vaccine Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 7.3.8 Greece 8 Asia Pacific 8.1 Asia Pacific Veterinary Vaccine Market Size by Type 8.1.1 Asia Pacific Veterinary Vaccine Sales by Type (2017-2028) 8.1.2 Asia Pacific Veterinary Vaccine Revenue by Type (2017-2028) 8.2 Asia Pacific Veterinary Vaccine Market Size by Application 8.2.1 Asia Pacific Veterinary Vaccine Sales by Application (2017-2028) 8.2.2 Asia Pacific Veterinary Vaccine Revenue by Application (2017-2028) 8.3 Asia Pacific Veterinary Vaccine Market Size by Region 8.3.1 Asia Pacific Veterinary Vaccine Sales by Region (2017-2028) 8.3.2 Asia Pacific Veterinary Vaccine Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Veterinary Vaccine Market Size by Type 9.1.1 Latin America Veterinary Vaccine Sales by Type (2017-2028) 9.1.2 Latin America Veterinary Vaccine Revenue by Type (2017-2028) 9.2 Latin America Veterinary Vaccine Market Size by Application 9.2.1 Latin America Veterinary Vaccine Sales by Application (2017-2028) 9.2.2 Latin America Veterinary Vaccine Revenue by Application (2017-2028) 9.3 Latin America Veterinary Vaccine Market Size by Country 9.3.1 Latin America Veterinary Vaccine Sales by Country (2017-2028) 9.3.2 Latin America Veterinary Vaccine Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Veterinary Vaccine Market Size by Type 10.1.1 Middle East and Africa Veterinary Vaccine Sales by Type (2017-2028) 10.1.2 Middle East and Africa Veterinary Vaccine Revenue by Type (2017-2028) 10.2 Middle East and Africa Veterinary Vaccine Market Size by Application 10.2.1 Middle East and Africa Veterinary Vaccine Sales by Application (2017-2028) 10.2.2 Middle East and Africa Veterinary Vaccine Revenue by Application (2017-2028) 10.3 Middle East and Africa Veterinary Vaccine Market Size by Country 10.3.1 Middle East and Africa Veterinary Vaccine Sales by Country (2017-2028) 10.3.2 Middle East and Africa Veterinary Vaccine Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 10.3.6 Egypt 10.3.7 South Africa 10.3.8 Israel 10.3.9 Kuwait 11 Company Profiles 11.1 Merck 11.1.1 Merck Corporation Information 11.1.2 Merck Overview 11.1.3 Merck Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Merck Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Merck Recent Developments 11.2 Zoetis 11.2.1 Zoetis Corporation Information 11.2.2 Zoetis Overview 11.2.3 Zoetis Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Zoetis Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Zoetis Recent Developments 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Corporation Information 11.3.2 Boehringer Ingelheim Overview 11.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Boehringer Ingelheim Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Boehringer Ingelheim Recent Developments 11.4 Ceva 11.4.1 Ceva Corporation Information 11.4.2 Ceva Overview 11.4.3 Ceva Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Ceva Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Ceva Recent Developments 11.5 CAHIC 11.5.1 CAHIC Corporation Information 11.5.2 CAHIC Overview 11.5.3 CAHIC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 CAHIC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 CAHIC Recent Developments 11.6 HVRI 11.6.1 HVRI Corporation Information 11.6.2 HVRI Overview 11.6.3 HVRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 HVRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 HVRI Recent Developments 11.7 Ringpu Biology 11.7.1 Ringpu Biology Corporation Information 11.7.2 Ringpu Biology Overview 11.7.3 Ringpu Biology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Ringpu Biology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Ringpu Biology Recent Developments 11.8 Yebio 11.8.1 Yebio Corporation Information 11.8.2 Yebio Overview 11.8.3 Yebio Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Yebio Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Yebio Recent Developments 11.9 DHN 11.9.1 DHN Corporation Information 11.9.2 DHN Overview 11.9.3 DHN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 DHN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 DHN Recent Developments 11.10 WINSUN 11.10.1 WINSUN Corporation Information 11.10.2 WINSUN Overview 11.10.3 WINSUN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 WINSUN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 WINSUN Recent Developments 11.11 Elanco 11.11.1 Elanco Corporation Information 11.11.2 Elanco Overview 11.11.3 Elanco Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Elanco Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Elanco Recent Developments 11.12 Virbac 11.12.1 Virbac Corporation Information 11.12.2 Virbac Overview 11.12.3 Virbac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Virbac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Virbac Recent Developments 11.13 Jinyu Bio-Technology 11.13.1 Jinyu Bio-Technology Corporation Information 11.13.2 Jinyu Bio-Technology Overview 11.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Jinyu Bio-Technology Recent Developments 11.14 ChengDu Tecbond 11.14.1 ChengDu Tecbond Corporation Information 11.14.2 ChengDu Tecbond Overview 11.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 ChengDu Tecbond Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 ChengDu Tecbond Recent Developments 11.15 CAVAC 11.15.1 CAVAC Corporation Information 11.15.2 CAVAC Overview 11.15.3 CAVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 CAVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 CAVAC Recent Developments 11.16 Kyoto Biken Laboratories 11.16.1 Kyoto Biken Laboratories Corporation Information 11.16.2 Kyoto Biken Laboratories Overview 11.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Kyoto Biken Laboratories Recent Developments 11.17 FATRO 11.17.1 FATRO Corporation Information 11.17.2 FATRO Overview 11.17.3 FATRO Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.17.4 FATRO Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 FATRO Recent Developments 11.18 Vaksindo 11.18.1 Vaksindo Corporation Information 11.18.2 Vaksindo Overview 11.18.3 Vaksindo Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.18.4 Vaksindo Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.18.5 Vaksindo Recent Developments 11.19 Bio-Labs 11.19.1 Bio-Labs Corporation Information 11.19.2 Bio-Labs Overview 11.19.3 Bio-Labs Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.19.4 Bio-Labs Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.19.5 Bio-Labs Recent Developments 11.20 Avimex Animal Health 11.20.1 Avimex Animal Health Corporation Information 11.20.2 Avimex Animal Health Overview 11.20.3 Avimex Animal Health Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.20.4 Avimex Animal Health Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.20.5 Avimex Animal Health Recent Developments 11.21 MEVAC 11.21.1 MEVAC Corporation Information 11.21.2 MEVAC Overview 11.21.3 MEVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.21.4 MEVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.21.5 MEVAC Recent Developments 11.22 Biovac 11.22.1 Biovac Corporation Information 11.22.2 Biovac Overview 11.22.3 Biovac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.22.4 Biovac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.22.5 Biovac Recent Developments 11.23 Atafen 11.23.1 Atafen Corporation Information 11.23.2 Atafen Overview 11.23.3 Atafen Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.23.4 Atafen Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.23.5 Atafen Recent Developments 11.24 Dyntec 11.24.1 Dyntec Corporation Information 11.24.2 Dyntec Overview 11.24.3 Dyntec Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.24.4 Dyntec Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.24.5 Dyntec Recent Developments 11.25 BioTestLab 11.25.1 BioTestLab Corporation Information 11.25.2 BioTestLab Overview 11.25.3 BioTestLab Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.25.4 BioTestLab Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.25.5 BioTestLab Recent Developments 11.26 RVSRI 11.26.1 RVSRI Corporation Information 11.26.2 RVSRI Overview 11.26.3 RVSRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.26.4 RVSRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.26.5 RVSRI Recent Developments 11.27 Medion 11.27.1 Medion Corporation Information 11.27.2 Medion Overview 11.27.3 Medion Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.27.4 Medion Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.27.5 Medion Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Veterinary Vaccine Industry Chain Analysis 12.2 Veterinary Vaccine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Veterinary Vaccine Production Mode & Process 12.4 Veterinary Vaccine Sales and Marketing 12.4.1 Veterinary Vaccine Sales Channels 12.4.2 Veterinary Vaccine Distributors 12.5 Veterinary Vaccine Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Veterinary Vaccine Industry Trends 13.2 Veterinary Vaccine Market Drivers 13.3 Veterinary Vaccine Market Challenges 13.4 Veterinary Vaccine Market Restraints 14 Key Findings in The Global Veterinary Vaccine Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
List of Tables Table 1. Global Veterinary Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Live Attenuated Vaccines Table 3. Major Manufacturers of Inactivated Vaccines Table 4. Major Manufacturers of Others Table 5. Global Veterinary Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Veterinary Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Veterinary Vaccine Sales by Region (2017-2022) & (M Doses) Table 8. Global Veterinary Vaccine Sales Market Share by Region (2017-2022) Table 9. Global Veterinary Vaccine Sales by Region (2023-2028) & (M Doses) Table 10. Global Veterinary Vaccine Sales Market Share by Region (2023-2028) Table 11. Global Veterinary Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Veterinary Vaccine Revenue Market Share by Region (2017-2022) Table 13. Global Veterinary Vaccine Revenue by Region (2023-2028) & (US$ Million) Table 14. Global Veterinary Vaccine Revenue Market Share by Region (2023-2028) Table 15. Global Veterinary Vaccine Sales by Manufacturers (2017-2022) & (M Doses) Table 16. Global Veterinary Vaccine Sales Share by Manufacturers (2017-2022) Table 17. Global Veterinary Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global Veterinary Vaccine Revenue Share by Manufacturers (2017-2022) Table 19. Veterinary Vaccine Price by Manufacturers (2017-2022) &(USD/Doses) Table 20. Global Veterinary Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2021) Table 22. Veterinary Vaccine Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Veterinary Vaccine Product Offered Table 24. Date of Manufacturers Enter into Veterinary Vaccine Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Veterinary Vaccine Sales by Type (2017-2022) & (M Doses) Table 27. Global Veterinary Vaccine Sales by Type (2023-2028) & (M Doses) Table 28. Global Veterinary Vaccine Sales Share by Type (2017-2022) Table 29. Global Veterinary Vaccine Sales Share by Type (2023-2028) Table 30. Global Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 31. Global Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 32. Global Veterinary Vaccine Revenue Share by Type (2017-2022) Table 33. Global Veterinary Vaccine Revenue Share by Type (2023-2028) Table 34. Veterinary Vaccine Price by Type (2017-2022) & (USD/Doses) Table 35. Global Veterinary Vaccine Price Forecast by Type (2023-2028) & (USD/Doses) Table 36. Global Veterinary Vaccine Sales by Application (2017-2022) & (M Doses) Table 37. Global Veterinary Vaccine Sales by Application (2023-2028) & (M Doses) Table 38. Global Veterinary Vaccine Sales Share by Application (2017-2022) Table 39. Global Veterinary Vaccine Sales Share by Application (2023-2028) Table 40. Global Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 41. Global Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 42. Global Veterinary Vaccine Revenue Share by Application (2017-2022) Table 43. Global Veterinary Vaccine Revenue Share by Application (2023-2028) Table 44. Veterinary Vaccine Price by Application (2017-2022) & (USD/Doses) Table 45. Global Veterinary Vaccine Price Forecast by Application (2023-2028) & (USD/Doses) Table 46. North America Veterinary Vaccine Sales by Type (2017-2022) & (M Doses) Table 47. North America Veterinary Vaccine Sales by Type (2023-2028) & (M Doses) Table 48. North America Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 49. North America Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 50. North America Veterinary Vaccine Sales by Application (2017-2022) & (M Doses) Table 51. North America Veterinary Vaccine Sales by Application (2023-2028) & (M Doses) Table 52. North America Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 53. North America Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 54. North America Veterinary Vaccine Sales by Country (2017-2022) & (M Doses) Table 55. North America Veterinary Vaccine Sales by Country (2023-2028) & (M Doses) Table 56. North America Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 57. North America Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe Veterinary Vaccine Sales by Type (2017-2022) & (M Doses) Table 59. Europe Veterinary Vaccine Sales by Type (2023-2028) & (M Doses) Table 60. Europe Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe Veterinary Vaccine Sales by Application (2017-2022) & (M Doses) Table 63. Europe Veterinary Vaccine Sales by Application (2023-2028) & (M Doses) Table 64. Europe Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe Veterinary Vaccine Sales by Country (2017-2022) & (M Doses) Table 67. Europe Veterinary Vaccine Sales by Country (2023-2028) & (M Doses) Table 68. Europe Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific Veterinary Vaccine Sales by Type (2017-2022) & (M Doses) Table 71. Asia Pacific Veterinary Vaccine Sales by Type (2023-2028) & (M Doses) Table 72. Asia Pacific Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific Veterinary Vaccine Sales by Application (2017-2022) & (M Doses) Table 75. Asia Pacific Veterinary Vaccine Sales by Application (2023-2028) & (M Doses) Table 76. Asia Pacific Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific Veterinary Vaccine Sales by Region (2017-2022) & (M Doses) Table 79. Asia Pacific Veterinary Vaccine Sales by Region (2023-2028) & (M Doses) Table 80. Asia Pacific Veterinary Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific Veterinary Vaccine Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America Veterinary Vaccine Sales by Type (2017-2022) & (M Doses) Table 83. Latin America Veterinary Vaccine Sales by Type (2023-2028) & (M Doses) Table 84. Latin America Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America Veterinary Vaccine Sales by Application (2017-2022) & (M Doses) Table 87. Latin America Veterinary Vaccine Sales by Application (2023-2028) & (M Doses) Table 88. Latin America Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America Veterinary Vaccine Sales by Country (2017-2022) & (M Doses) Table 91. Latin America Veterinary Vaccine Sales by Country (2023-2028) & (M Doses) Table 92. Latin America Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa Veterinary Vaccine Sales by Type (2017-2022) & (M Doses) Table 95. Middle East and Africa Veterinary Vaccine Sales by Type (2023-2028) & (M Doses) Table 96. Middle East and Africa Veterinary Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa Veterinary Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa Veterinary Vaccine Sales by Application (2017-2022) & (M Doses) Table 99. Middle East and Africa Veterinary Vaccine Sales by Application (2023-2028) & (M Doses) Table 100. Middle East and Africa Veterinary Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa Veterinary Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa Veterinary Vaccine Sales by Country (2017-2022) & (M Doses) Table 103. Middle East and Africa Veterinary Vaccine Sales by Country (2023-2028) & (M Doses) Table 104. Middle East and Africa Veterinary Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa Veterinary Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 106. Merck Corporation Information Table 107. Merck Description and Major Businesses Table 108. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 109. Merck Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Merck Recent Developments Table 111. Zoetis Corporation Information Table 112. Zoetis Description and Major Businesses Table 113. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 114. Zoetis Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 115. Zoetis Recent Developments Table 116. Boehringer Ingelheim Corporation Information Table 117. Boehringer Ingelheim Description and Major Businesses Table 118. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 119. Boehringer Ingelheim Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Boehringer Ingelheim Recent Developments Table 121. Ceva Corporation Information Table 122. Ceva Description and Major Businesses Table 123. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 124. Ceva Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Ceva Recent Developments Table 126. CAHIC Corporation Information Table 127. CAHIC Description and Major Businesses Table 128. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 129. CAHIC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 130. CAHIC Recent Developments Table 131. HVRI Corporation Information Table 132. HVRI Description and Major Businesses Table 133. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 134. HVRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 135. HVRI Recent Developments Table 136. Ringpu Biology Corporation Information Table 137. Ringpu Biology Description and Major Businesses Table 138. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 139. Ringpu Biology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Ringpu Biology Recent Developments Table 141. Yebio Corporation Information Table 142. Yebio Description and Major Businesses Table 143. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 144. Yebio Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 145. Yebio Recent Developments Table 146. DHN Corporation Information Table 147. DHN Description and Major Businesses Table 148. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 149. DHN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 150. DHN Recent Developments Table 151. WINSUN Corporation Information Table 152. WINSUN Description and Major Businesses Table 153. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 154. WINSUN Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 155. WINSUN Recent Developments Table 156. Elanco Corporation Information Table 157. Elanco Description and Major Businesses Table 158. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 159. Elanco Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 160. Elanco Recent Developments Table 161. Virbac Corporation Information Table 162. Virbac Description and Major Businesses Table 163. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 164. Virbac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 165. Virbac Recent Developments Table 166. Jinyu Bio-Technology Corporation Information Table 167. Jinyu Bio-Technology Description and Major Businesses Table 168. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 169. Jinyu Bio-Technology Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 170. Jinyu Bio-Technology Recent Developments Table 171. ChengDu Tecbond Corporation Information Table 172. ChengDu Tecbond Description and Major Businesses Table 173. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 174. ChengDu Tecbond Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 175. ChengDu Tecbond Recent Developments Table 176. CAVAC Corporation Information Table 177. CAVAC Description and Major Businesses Table 178. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 179. CAVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 180. CAVAC Recent Developments Table 181. Kyoto Biken Laboratories Corporation Information Table 182. Kyoto Biken Laboratories Description and Major Businesses Table 183. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 184. Kyoto Biken Laboratories Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 185. Kyoto Biken Laboratories Recent Developments Table 186. FATRO Corporation Information Table 187. FATRO Description and Major Businesses Table 188. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 189. FATRO Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 190. FATRO Recent Developments Table 191. Vaksindo Corporation Information Table 192. Vaksindo Description and Major Businesses Table 193. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 194. Vaksindo Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 195. Vaksindo Recent Developments Table 196. Bio-Labs Corporation Information Table 197. Bio-Labs Description and Major Businesses Table 198. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 199. Bio-Labs Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 200. Bio-Labs Recent Developments Table 201. Avimex Animal Health Corporation Information Table 202. Avimex Animal Health Description and Major Businesses Table 203. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 204. Avimex Animal Health Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 205. Avimex Animal Health Recent Developments Table 206. MEVAC Corporation Information Table 207. MEVAC Description and Major Businesses Table 208. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 209. MEVAC Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 210. MEVAC Recent Developments Table 211. Biovac Corporation Information Table 212. Biovac Description and Major Businesses Table 213. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 214. Biovac Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 215. Biovac Recent Developments Table 216. Atafen Corporation Information Table 217. Atafen Description and Major Businesses Table 218. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 219. Atafen Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 220. Atafen Recent Developments Table 221. Dyntec Corporation Information Table 222. Dyntec Description and Major Businesses Table 223. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 224. Dyntec Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 225. Dyntec Recent Developments Table 226. BioTestLab Corporation Information Table 227. BioTestLab Description and Major Businesses Table 228. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 229. BioTestLab Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 230. BioTestLab Recent Developments Table 231. RVSRI Corporation Information Table 232. RVSRI Description and Major Businesses Table 233. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 234. RVSRI Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 235. RVSRI Recent Developments Table 236. Medion Corporation Information Table 237. Medion Description and Major Businesses Table 238. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022) Table 239. Medion Veterinary Vaccine Product Model Numbers, Pictures, Descriptions and Specifications Table 240. Medion Recent Developments Table 241. Key Raw Materials Lists Table 242. Raw Materials Key Suppliers Lists Table 243. Veterinary Vaccine Distributors List Table 244. Veterinary Vaccine Customers List Table 245. Veterinary Vaccine Market Trends Table 246. Veterinary Vaccine Market Drivers Table 247. Veterinary Vaccine Market Challenges Table 248. Veterinary Vaccine Market Restraints Table 249. Research Programs/Design for This Report Table 250. Key Data Information from Secondary Sources Table 251. Key Data Information from Primary Sources List of Figures Figure 1. Veterinary Vaccine Product Picture Figure 3. Global Veterinary Vaccine Market Share by Type in 2021 & 2028 Figure 3. Live Attenuated Vaccines Product Picture Figure 4. Inactivated Vaccines Product Picture Figure 5. Others Product Picture Figure 6. Global Veterinary Vaccine Market Share by Application in 2021 & 2028 Figure 7. Livestock Figure 8. Swine Figure 9. Chicken Figure 10. Dog & Cat Figure 11. Others Figure 12. Veterinary Vaccine Report Years Considered Figure 13. Global Veterinary Vaccine Sales 2017-2028 (M Doses) Figure 14. Global Veterinary Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Veterinary Vaccine Revenue 2017-2028 (US$ Million) Figure 16. Global Veterinary Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 17. Global Veterinary Vaccine Sales Market Share by Region (2017-2022) Figure 18. Global Veterinary Vaccine Sales Market Share by Region (2023-2028) Figure 19. North America Veterinary Vaccine Sales YoY (2017-2028) & (M Doses) Figure 20. North America Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 21. Europe Veterinary Vaccine Sales YoY (2017-2028) & (M Doses) Figure 22. Europe Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 23. Asia-Pacific Veterinary Vaccine Sales YoY (2017-2028) & (M Doses) Figure 24. Asia-Pacific Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 25. Latin America Veterinary Vaccine Sales YoY (2017-2028) & (M Doses) Figure 26. Latin America Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 27. Middle East & Africa Veterinary Vaccine Sales YoY (2017-2028) & (M Doses) Figure 28. Middle East & Africa Veterinary Vaccine Revenue YoY (2017-2028) & (US$ Million) Figure 29. The Veterinary Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 30. The Top 5 and 10 Largest Manufacturers of Veterinary Vaccine in the World: Market Share by Veterinary Vaccine Revenue in 2021 Figure 31. Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 32. Global Veterinary Vaccine Sales Market Share by Type (2017-2028) Figure 33. Global Veterinary Vaccine Revenue Market Share by Type (2017-2028) Figure 34. Global Veterinary Vaccine Sales Market Share by Application (2017-2028) Figure 35. Global Veterinary Vaccine Revenue Market Share by Application (2017-2028) Figure 36. North America Veterinary Vaccine Sales Market Share by Type (2017-2028) Figure 37. North America Veterinary Vaccine Revenue Market Share by Type (2017-2028) Figure 38. North America Veterinary Vaccine Sales Market Share by Application (2017-2028) Figure 39. North America Veterinary Vaccine Revenue Market Share by Application (2017-2028) Figure 40. North America Veterinary Vaccine Sales Share by Country (2017-2028) Figure 41. North America Veterinary Vaccine Revenue Share by Country (2017-2028) Figure 42. U.S. Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 43. Canada Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 44. Europe Veterinary Vaccine Sales Market Share by Type (2017-2028) Figure 45. Europe Veterinary Vaccine Revenue Market Share by Type (2017-2028) Figure 46. Europe Veterinary Vaccine Sales Market Share by Application (2017-2028) Figure 47. Europe Veterinary Vaccine Revenue Market Share by Application (2017-2028) Figure 48. Europe Veterinary Vaccine Sales Share by Country (2017-2028) Figure 49. Europe Veterinary Vaccine Revenue Share by Country (2017-2028) Figure 50. Germany Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 51. France Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 52. U.K. Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 53. Italy Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 54. Russia Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 55. Greece Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 56. Ukraine Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 57. Asia Pacific Veterinary Vaccine Sales Market Share by Type (2017-2028) Figure 58. Asia Pacific Veterinary Vaccine Revenue Market Share by Type (2017-2028) Figure 59. Asia Pacific Veterinary Vaccine Sales Market Share by Application (2017-2028) Figure 60. Asia Pacific Veterinary Vaccine Revenue Market Share by Application (2017-2028) Figure 61. Asia Pacific Veterinary Vaccine Sales Share by Region (2017-2028) Figure 62. Asia Pacific Veterinary Vaccine Revenue Share by Region (2017-2028) Figure 63. China Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 64. Japan Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 65. South Korea Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 66. India Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 67. Australia Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 68. Taiwan Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 69. Indonesia Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 70. Thailand Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 71. Malaysia Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 72. Philippines Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 73. Latin America Veterinary Vaccine Sales Market Share by Type (2017-2028) Figure 74. Latin America Veterinary Vaccine Revenue Market Share by Type (2017-2028) Figure 75. Latin America Veterinary Vaccine Sales Market Share by Application (2017-2028) Figure 76. Latin America Veterinary Vaccine Revenue Market Share by Application (2017-2028) Figure 77. Latin America Veterinary Vaccine Sales Share by Country (2017-2028) Figure 78. Latin America Veterinary Vaccine Revenue Share by Country (2017-2028) Figure 79. Mexico Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 80. Brazil Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 81. Argentina Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 82. Middle East and Africa Veterinary Vaccine Sales Market Share by Type (2017-2028) Figure 83. Middle East and Africa Veterinary Vaccine Revenue Market Share by Type (2017-2028) Figure 84. Middle East and Africa Veterinary Vaccine Sales Market Share by Application (2017-2028) Figure 85. Middle East and Africa Veterinary Vaccine Revenue Market Share by Application (2017-2028) Figure 86. Middle East and Africa Veterinary Vaccine Sales Share by Country (2017-2028) Figure 87. Middle East and Africa Veterinary Vaccine Revenue Share by Country (2017-2028) Figure 88. Turkey Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 89. Saudi Arabia Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 90. U.A.E Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 91. Egypt Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 92. South Africa Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 93. Israel Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 94. Kuwait Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 95. Iran Veterinary Vaccine Revenue (2017-2028) & (US$ Million) Figure 96. Veterinary Vaccine Value Chain Figure 97. Veterinary Vaccine Production Process Figure 98. Channels of Distribution Figure 99. Distributors Profiles Figure 100. Bottom-up and Top-down Approaches for This Report Figure 101. Data Triangulation Figure 102. Key Executives Interviewed